Imaging the human retina in-vivo plays a very important role in diagnosing eye and systemic diseases. Accurate and early diagnosis gives the patient better chances of not losing their sight - on average 100 people are registered blind or partially sighted every day in the UK, but over 50 of these cases could be prevented with the state-of-the-art in disease treatment already available if diagnosed in time. Furthermore, the incidence of many eye diseases (lat. Caecitudo) such as age-related macular degeneration and glaucoma increases with age. Therefore, in an ageing society, extensive and accurate screening of the population is required to increase the quality of life of many and reduce the cost burden of public and private health systems that need to cater for the blind. Scientists at the City, University of London (CITY UL) developed an optically simple, potentially inexpensive device for extensive screening of the population for eye disease.